These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10122415)

  • 21. Prescription drug benefits: Rx for cost management--commentary.
    Carlsen MA
    Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug inflation exaggerated--GAO.
    Gardner J
    Mod Healthc; 1995 Jun; 25(23):8. PubMed ID: 10142727
    [No Abstract]   [Full Text] [Related]  

  • 23. Prescription drug prices: why do some pay more than others do?
    Frank RG
    Health Aff (Millwood); 2001; 20(2):115-28. PubMed ID: 11260933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic drug prices fall overall in '94.
    Hosp Mater Manage; 1995 Feb; 20(2):1, 12-3. PubMed ID: 10140171
    [No Abstract]   [Full Text] [Related]  

  • 25. 1993 changes in drug cost for inpatient services.
    Mehl B
    Hosp Pharm; 1994 Aug; 29(8):771-3. PubMed ID: 10171916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. America's pharmaceutical research companies: keeping the cost of health care down. Pharmaceutical Manufacturers Association.
    Hawaii Med J; 1992 Jan; 51(1):15-16, 19. PubMed ID: 1740387
    [No Abstract]   [Full Text] [Related]  

  • 27. Screaming for relief.
    Cooper M
    Time; 1999 Nov; 154(21):38-42, 44. PubMed ID: 10622838
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of being first: evidence from Canadian generic pharmaceuticals.
    Hollis A
    Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 30. Sanofi vows to limit price hikes- but will it make much difference?
    Kacik A
    Mod Healthc; 2017 May; 47(20):12. PubMed ID: 30496647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rx: higher prices.
    Kosterlitz J
    Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem.
    Hollis A; Grootendorst P
    Healthc Policy; 2015 Aug; 11(1):10-4. PubMed ID: 26571465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comments on the editorial "The health sector and the perpetual murkiness in the relations between the medical profession and the drug industry" ].
    Oteo Ochoa LA
    Rev Calid Asist; 2009 Aug; 24(4):178-81. PubMed ID: 19647681
    [No Abstract]   [Full Text] [Related]  

  • 34. Opinion: price controls on prescription drugs.
    Franks B
    N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
    [No Abstract]   [Full Text] [Related]  

  • 35. A dose of higher costs. With drug manufacturers being hit with new fees from distributors, providers and GPOs face new pricing pressures.
    Becker C
    Mod Healthc; 2004 Sep; 34(36):4-5, 10-1, 1. PubMed ID: 15458169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rx: Canadian drugs.
    Bugden S
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15014193
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
    Augurzky B; Göhlmann S; Gress S; Wasem J
    Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Policy-Driven Perspective on Rising Drug Costs in Dermatology.
    Nguyen HP; Forman HP
    JAMA Dermatol; 2016 Jun; 152(6):625-6. PubMed ID: 27008060
    [No Abstract]   [Full Text] [Related]  

  • 39. Copayment coupons undermine formularies.
    Manag Care; 2011 Dec; 20(12):63. PubMed ID: 22259878
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors contributing to trends in prescription drug expenditures.
    Suh DC; Lacy CR; Barone JA; Moylan D; Kostis JB
    Clin Ther; 1999 Jul; 21(7):1241-53. PubMed ID: 10463521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.